This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Institut Gustave Roussy, National Institute of Health and Medical Research. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 101 
1 out of 1,853 
Years Active: 2013
Title: Faten El Hage: Innovator in Cancer Immunotherapy
Introduction
Faten El Hage is a notable inventor based in Paris, France. She has made significant contributions to the field of cancer immunotherapy through her innovative research and patents. Her work focuses on the development of therapeutic approaches that harness the body's immune system to combat cancer.
Latest Patents
Faten El Hage holds a patent for "Preprocalcitonin antigen T epitopes." This invention is related to the presentation of Preprocalcitonin antigen T epitopes by the Major Histocompatibility Complex I (MHC I). These peptides have potential applications in cancer immunotherapy, offering new avenues for treatment.
Career Highlights
Throughout her career, Faten has worked with prestigious institutions such as the Institut Gustave Roussy and the Institut National de la Santé et de la Recherche Médicale. Her experience in these organizations has allowed her to contribute to groundbreaking research in the medical field.
Collaborations
Faten has collaborated with esteemed colleagues, including Vincent Stroobant and Pierre G. Coulie. These partnerships have enriched her research and expanded the impact of her work in cancer immunotherapy.
Conclusion
Faten El Hage is a pioneering inventor whose work in cancer immunotherapy is paving the way for innovative treatments. Her contributions, including her patent on Preprocalcitonin antigen T epitopes, highlight her commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile